secwatch.observer — SEC 8-K summary
======================================

Issuer:     Inspire Medical Systems, Inc. (INSP)
CIK:        0001609550
Form:       8-K
Filed at:   2024-05-07T23:59:59+00:00
Accession:  0001609550-24-000024
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Inspire Medical Q1 revenue $164M (+28% YoY); raises FY2024 guidance, expects full-year profitability
--------------------------------------------------------------------------------

- Q1 2024 revenue $164.0M, up 28% YoY; net loss narrowed to $10.0M ($0.34/share) from $15.4M.
- U.S. revenue $155.8M (+25% YoY); OUS revenue $8.2M (+141%); gross margin 84.9% vs 84.4%.
- FY2024 revenue guidance raised to $783-793M (25-27% growth); first-time diluted EPS guidance $0.10-$0.20.
- Added 66 new U.S. centers (total 1,246) and 11 new sales territories (total 298) in Q1.
- Ended Q1 with $469.2M cash; expects full-year 2024 profitability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/0001609550-24-000024-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1609550/000160955024000024/insp-20240507.htm
  HTML page:      https://secwatch.observer/filing/0001609550-24-000024

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer